U.S. market Closed. Opens in 2 days 5 hours 3 minutes

SWAV | ShockWave Medical, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 334.75 - 334.75
52 Week Range 157.00 - 334.90
Beta 1.12
Implied Volatility 45.46%
IV Rank 0.14%
Day's Volume N/A
Average Volume 1,390,519
Shares Outstanding 37,543,500
Market Cap 12,567,686,625
Sector Healthcare
Industry Medical - Devices
IPO Date 2019-03-07
Valuation
Profitability
Growth
Health
P/E Ratio 78.76
Forward P/E Ratio 68.44
EPS 4.25
1YR Price Target 255.50
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,468
Country USA
Website SWAV
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.
SWAV's peers: ALGN, BFLY, BIO, CLPT, DXCM, INMD, INOV, INSP, MASI, NARI, NNOX, NVCR, OM, PEN, PODD, QDEL, TMDX, TNDM
*Chart delayed
Analyzing fundamentals for SWAV we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is wealthy, Growth is exceptionally good and Health is strong. For more detailed analysis please see SWAV Fundamentals page.

Watching at SWAV technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on SWAV Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙